Please login to the form below

Not currently logged in
Email:
Password:

off-label information

This page shows the latest off-label information news and features for those working in and with pharma, biotech and healthcare.

Celebrating excellence

Celebrating excellence

The Lilly Medical Cascade, which is currently being rolled-out throughout the industry, across brands and around the world, can be used for both on- and off-label information. ... The PMEA judges said: “This was a real first - a verified product

Latest news

  • Blue Latitude's industry-first praised at PMEA Blue Latitude's industry-first praised at PMEA

    The Lilly Medical Cascade, which is currently being rolled-out throughout the industry, across brands and around the world, can be used for both on- and off-label information. . ... The PMEA judges said: “This was a real first - a verified product

  • Pharma lobbying in the US Pharma lobbying in the US

    That we need to distinguish between 'active' off-label promotion and unsolicited off-label requests from clinicians because somewhere and somehow the information that helps advance treatment needs to be shared. ... It has become a conversation about how

  • FDA releases draft social media guidance FDA releases draft social media guidance

    no other control or influence on that site, then the firm is not responsible for information on a third-party site. ... It will then add to a growing body of digital guidance from the FDA that so far covers off-label information on social media and a

  • US think tank suggests ‘social guiding principles’ for pharma

    The regulator held a two-day public hearing on pharma's use of social media and the internet in November 2009 but, apart from some direction on how to treat ... label information requests, has yet to publish guidance on the area.

  • FDA boosts its social media use with the launch of a new blog

    Through FDA Voice the regulator aims to provide “information from behind the scenes here at FDA”, as FDA Commissioner Margaret Hamburg put in an introductory post. ... But the Agency's recommendations were limited to how pharma companies respond to

More from news
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...